Opportunity
Injectable Influenza Vaccine
Response due
September 7, 2026
- Buyer
- DLA Troop Support
- Agency
- DLA Troop Support
- Estimated value
- Not stated
The Defense Logistics Agency Troop Support is soliciting for the supply of Injectable Influenza Vaccine for the 2027-2028 flu season. Approximately 1.5 million doses are included in this requirement. (Quantities may increase or decrease pending receipt of final Service requirements.) The vaccines shall be in prefilled syringes presentation. The vaccine shall be FDA-approved for the following age categories: for immunizing individuals 65 years and older, for immunizing individuals 18 years and older, for immunizing individuals 3 years and older, and for immunizing 6 months to 35 months (pediatric group). The formula for the 2027-2028 season shall be determined by the U.S. Food & Drug Administration (FDA) Vaccines and Related Biological Products Advisory Committee. Other specification data is included in the solicitation. Successful contractor must have FDA Approval, and the vaccine must be U.S. Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP) recommended. National Stock Numbers shall be established at the time of award. An indefinite quantity contract is proposed. The quantity indicated is an annual estimate only. The guaranteed minimum will be 75% of the annual estimate, and a contract maximum will be established at 150% of the annual estimate. All quantities shall be delivered to the Defense Depot New Cumberland, PA. The contractor shall be capable of delivering 40% of the requirement by August 12, 2027, 25% by August 26, 2027, 25% by September 9, 2027, and the residual 10% by September 23, 2027. This delivery schedule is the preferred delivery schedule. Other delivery schedules may be considered. A copy of the solicitation will be posted to the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil and SAM.gov at https://www.sam.gov. Interested parties should contact Rosbert Jones (445-737-1254) (Rosbert.Jones@dla.mil) for any questions/comments. Interested parties are further advised to set up automated notifications of presolicitation or solicitation changes through this website. The current projected solicitation date is October of 2026. DLA reserves the right to issue the solicitation before or after the projected solicitation date.
Key dates
- Posted
- August 24, 2026
- Response due
- September 7, 2026
Who is this buyer
Organization
Buying history
- Records547 total
- Opportunities / awards10 / 411
- Value range$0 – $330,000,000
- ActiveJuly 13, 2026 – October 27, 2026
What they buy
- Clinical (544)
- Administrative (3)
Set-asides used
- Small Business Set Aside - Total (54)
- SDVOSB Set-Aside (FAR 19.14) (11)
- WOSB Program Set-Aside (FAR 19.15) (9)
- No Set aside used (6)
Who holds their work today
- GOLDEN STATE MEDICAL SUPPLY, INC.5 wins · $51,709,896 · last September 18, 2025
- VWR INTERNATIONAL LLC6 wins · $49,500,189 · last October 21, 2026
- CEPHEID1 win · $49,000,000 · last October 22, 2026
- Ethicon US LLC1 win · $48,000,000 · last October 8, 2026
- RADHA PHARMACEUTICALS INC1 win · $23,278,524 · last October 6, 2022
Also open from this buyer
- Methylphenidate ERDue November 6, 2026 · Clinical
- Medtronic cardiovascular "procedural packages"Due November 20, 2026 · Clinical
- Digital Imaging Network - Picture Archiving and Communication Systems (DIN-PACS) - Generation VDue October 14, 2031 · Clinical
- Epinephrine InjectorDue November 16, 2026 · Clinical
View source document →
Source link on sam.gov.
Source record
- Buyer type
- Federal
- Jurisdiction
- Federal (US)
- Category
- Clinical
- Set-aside
- Not stated
- NAICS
- 325414
- PSC
- 6505